Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Veracyte, Inc. (VCYT)  
$20.97 0.82 (3.76%) as of 4:30 Fri 6/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 82,823,000
Market Cap: 1.74(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.92 - $29.92
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  484
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Veracyte is a genomic diagnostics company. Co. develops tests that address clinical needs in the diagnosis, prognosis and treatment of cancer and other diseases. Co. provides tests in: thyroid cancer via its Afirma Genomic Sequencing Classifier (GSC) and Xpression Atlas; prostate cancer via its Decipher Biopsy and Radical Prostatectomy Genomic Classifiers; breast cancer via its Prosigna Breast Cancer Assay; lung cancer via its Percepta GSC and Percepta Nasal Swab Test; interstitial lung diseases including idiopathic pulmonary fibrosis via its Envisia Genomic Classifier; bladder cancer via its Decipher Bladder Genomic Classifier; and colon cancer via its Immunoscore Colon Cancer Test.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 21,779 31,779 114,409 523,205
Total Sell Value $459,589 $703,188 $3,171,383 $13,848,977
Total People Sold 2 3 4 6
Total Sell Transactions 5 6 15 32
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 551
  Page 9 of 23  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Anderson Bonnie H Chairman and CEO   •       •      –    2021-01-11 4 AS $49.81 $3,599,303 D/D (71,105) 203,756 -26%     
   Anderson Bonnie H Chairman and CEO   •       •      –    2021-01-11 4 OE $5.61 $610,741 D/D 71,105 274,861     -
   Gordon Kevin K Director   •       •      –    2021-01-04 4 AS $48.62 $489,798 D/D (10,000) 0 -26%     
   Gordon Kevin K Director   •       •      –    2021-01-04 4 OE $7.39 $73,900 D/D 10,000 10,000     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-12-29 4 OE $2.68 $116,919 D/D 31,313 203,756     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       •      –    2020-12-04 4 AS $55.78 $797,156 D/D (14,015) 78,312 -16%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       •      –    2020-12-04 4 OE $5.98 $150,209 D/D 13,468 92,327     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       •      –    2020-12-02 4 D $55.08 $29,743 D/D (540) 78,859     -
   Gordon Kevin K Director   •       •      –    2020-11-12 4 AS $46.95 $471,138 D/D (10,000) 0 8%     
   Gordon Kevin K Director   •       •      –    2020-11-12 4 OE $7.39 $73,900 D/D 10,000 10,000     -
   Ho Mark Principal Accounting Officer   •       •      –    2020-11-11 4 S $45.00 $624,375 D/D (13,875) 19,086 -2%     
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-11-10 4 GA $0.00 $0 I/I 45,812 47,906     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-11-10 4 GD $0.00 $0 D/D 45,812 174,419     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-11-10 4 OE $40.99 $849,929 D/D 20,000 220,231     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-11-10 4 OE $8.86 $177,200 D/D 20,000 240,231     -
   Hanna John Walter Jr Chief Commercial Officer   •       •      –    2020-11-06 4 AS $43.40 $923,106 D/D (21,250) 74,309 21%     
   Hanna John Walter Jr Chief Commercial Officer   •       •      –    2020-11-06 4 OE $20.21 $429,463 D/D 21,250 95,559     -
   Hanna John Walter Jr Chief Commercial Officer   •       •      –    2020-11-05 4 AS $40.00 $260,651 D/D (6,406) 74,309 19%     
   Hanna John Walter Jr Chief Commercial Officer   •       •      –    2020-11-05 4 OE $5.98 $47,902 D/D 6,406 80,715     -
   Ho Mark Principal Accounting Officer   •       •      –    2020-10-20 4 OE $6.45 $48,375 D/D 7,500 32,961     -
   Cohen Fred E Director   •       •      –    2020-10-19 4 OE $7.60 $76,000 D/D 10,000 10,000     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-10-08 4 AS $38.00 $1,900,000 D/D (50,000) 220,231 89%     
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-10-08 4 OE $8.86 $443,000 D/D 50,000 270,231     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       •      –    2020-10-06 4 AS $35.21 $88,025 D/D (2,500) 79,399 111%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       •      –    2020-10-06 4 OE $20.21 $50,525 D/D 2,500 81,899     -

  551 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 23
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed